1)Stewart WC, Chorak RP, Hunt HH et al:Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol 116:176-181, 1993
2)Thai JC:A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology 116(Suppl):S30-S36, 2009
3)Sleath B, Blalock S, Covert D et al:The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology 118:2398-2402, 2011
4)Taylor SA, Galbraith SM, Mills RP:Causes of non-compliance with drug regimens in glaucoma patients:a qualitative study. J Ocul Pharmacol Ther 18:401-409, 2002
5)Hennessy AL, Katz J, Covert D et al:A video study of drop instillation in both glaucoma and retina patients with visual impairment. Am J Ophthalmol 152:982-988, 2011
6)小林 博:緑内障点眼薬の補助具使用のアドヒアランス.臨眼68:1127-1132,2014
7)Kobayashi H:A change of consumed volume of anti-glaucoma drugs and intraocular pressure by using an eye drop aid. J Glaucoma(投稿中)
8)日本緑内障学会(編):緑内障ガイドライン(第3版).日眼会誌116:387-425,2012
9)小林 博・岩切 亮・小林かおり・他:緑内障患者の点眼状況.臨眼60:43-47,2006
10)Semes L, Shaikh AS. Evaluation of the Xal-Ease latanoprost delivery system. Optometry 78:30-33, 2007
11)Nordmann JP, Baudouin C, Bron A et al:Xal-Ease:impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction. Eur J Ophthalmol 19:949-956, 2009
12)Kahook MY. Developments in dosing aids and adherence devices for glaucoma therapy:current and future perspectives. Exper Rev Med Devices 4:261-266, 2007
13)森 千浩・池田陽子・森 和彦・他:点眼補助具使用の有無による1日当たり平均点眼使用量の差の検討.緑内障25:54-57,2015
14)Strungaru MH, Peck J, Compeau EC et al:Mirror-hat device as a drop delivery aid:a pilot study. Can J Ophthalmol 49:333-338, 2014